Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2020

Sep 11, 2020

59275_rns_2020-09-11_7f89f9e1-4d6c-4fb6-a767-163400309c3f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

11th September 2020

  • (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
  • (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 5th floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings

Dear Sir/Madam,

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company:

Date Fund / Investor Name Venue Type of Meeting
14-September-2020 Citi India GEMs Conference 2020
17-September-2020 Morgan Stanley 18th Annual GlobalHealthcare Conference - Call
18-September-2020 Capital Research Global Investors

The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on the part of Investors / Company.

Thanking you,

Yours faithfully,

For Cipla Limited

Rajendra Chopra Company Secretary

Prepared by: Juzer Masta